John Ripple
Executive Chair
CEO of 5 venture-backed biotech
companies, including Exonics Tx
(acquired by Vertex),
Virdante Pharmaceuticals (acquired by
Momenta), and Syntonix Pharma
(acquired by Biogen).
Mr. Ripple has held positions in business
development, entrepreneur-in-residence,
medical device marketing, and
management consulting,
Founded Ripple Biotech LLC to advise
biopharmaceutical companies